ArticleHealth promotion perspectives2021
Prioritizing 'equity' in COVID-19 vaccine distribution through Global Health Diplomacy.
Article in Health promotion perspectives, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 1 synthesis or guideline pooled it.
- On the momentum toward vaccine self-sufficiency in the BRICS: an integrative review of the role of pharmaceutical entrepreneurship and innovation.Frontiers in public health · 2023Pooled it
- Advancing Health Equity through 'One World for Health': Insights from the Seventy-Eighth World Health Assembly.Health promotion perspectives · 2026Article
- Equity in COVID-19 Vaccine Resource Distribution: An Exploration of Vaccine Uptake Among Health Workers in a Low-Income Setting.Healthcare (Basel, Switzerland) · 2026Article
- Review
- A Global Index to Quantify Discrimination Resulting from COVID-19 Pandemic Response Policies.International journal of environmental research and public health · 2025Article
- Evaluating geographic accessibility to COVID-19 vaccination across 54 countries/regions.BMJ global health · 2025Article
- Pandemic treaty as an instrument to strengthen global health security: Global health diplomacy at its crux.Health promotion perspectives · 2024Review
- The role of hesitancy and infrastructure in the equity and efficiency of COVID-19 vaccine administration.PloS one · 2024Article
- Incorporating migrants into National COVID-19 Vaccination Plans in Latin America: A comparative analysis of policies in seven countries.Journal of migration and health · 2024Article
- Association between Gross National Income per capita and COVID-19 vaccination coverage: a global ecological study.BMC public health · 2023Article
- COVID-19 and Global Distributive Justice: 'Health Diplomacy' of India and South Africa for the TRIPS waiver.Journal of Asian and African studies · 2023Article
- Geoepidemiological perspective on COVID-19 pandemic review, an insight into the global impact.Frontiers in public health · 2023Review
- An optimization framework for COVID-19 vaccine allocation and inventory management: A case study.Applied soft computing · 2023Article
- Editorial: Inequalities in COVID-19 healthcare and research affecting women.Frontiers in global women's health · 2023Article
- Article
- The rise of India's global health diplomacy amid COVID-19 pandemic.Health promotion perspectives · 2023Article
- Transmembrane protease serine 2 (Life science alliance · 2022Article
- Global Health Governance and Health Equity in the Context of COVID-19: A Scoping Review.Healthcare (Basel, Switzerland) · 2022Article
- Bayesian subjectivism and psychosocial attitude toward COVID-19 vaccines.F1000Research · 2022Article
- Global vaccine inequities and multilateralism amid COVID-19: Reconnaissance of Global Health Diplomacy as a panacea?Health promotion perspectives · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
With over 4 million deaths worldwide, the current coronavirus disease 2019 (COVID-19)pandemic is regarded as one of the worst pandemics in history. With its wider devastating consequences, even so-called affluent countries could not provide full coverage for COVID-19vaccines and medications to all of their citizens. Against this backdrop, the main aim of this article is to examine how Global Health Diplomacy (GHD) can play a role in prioritizing vaccine equity in the global health agenda in the fight against COVID-19. The majority of developed countries' healthcare systems have been exposed and have reached a tipping point.After the completion of eighteen months of the pandemic, only five countries were able to produce vaccines for the treatment of COVID-19. This pandemic has divided the world into two blocs: those with vaccines, such as the United States, the United Kingdom, Russia, China, and India; and those without, such as the rest of the world. The greatest challenges are vaccine inequalities, inequities and distribution, which undermine the global economic recovery. Many poor countries are still waiting for the initial doses to be delivered to their citizens, while some rich nations are planning for booster doses. GHD plays a critical role in establishing successful global collaborations, funding mechanisms and ensuring international cooperation through the combined efforts of all stakeholders. Besides, global solidarity is necessary to lessen the wider gaps between the vaccination status of rich and poor nations. Therefore, through GHD, the vaccine gaps and inequities can be addressed to strengthen global health security and accelerate global economic recovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.